I’ve been reading a bit of angst regarding covid trials, and announcements related to these trials. Admittedly I’m an engineer so a bit of a numpty at the best of times, but just trying to understand what I’m missing:
1) MSB as a company has had a fixed plan over a number of years for commercialisation of a number of products;
2) that plan hasn’t changed with the recent world events as far as I’m aware
3) (from an investors POV) covid-19 treatments are a bonus (and haven’t been priced in)
4) if 3 doesn’t eventuate, 1 ticks along as planned
I didn’t buy/hold msb hoping for a covid cure, but a bonus is a bonus. If, as a company they see value in diverting resources from the original plan In the short term to target this, ill trust their judgement that they view this as a value accretive move.
Provided this doesn’t alter the original plan at 1), why get worked up about not receiving warm and fuzzy’s about the add-on?
disclaimer: I hope msb and/or others are able to solve the covid dilemma, references to ‘bonus/add-on’ are purely from an unemotional investment pov
I’ve been reading a bit of angst regarding covid trials, and...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.005(0.42%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.14 | $10.44M | 8.934M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 45750 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 1476 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.18 |
Change
-0.005 ( 0.31 %) |
||||
| Open | High | Low | Volume | ||
| $1.18 | $1.20 | $1.14 | 1465927 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| MSB (ASX) Chart |